ANNX
Annexon Inc
NASDAQ: ANNX · HEALTHCARE · BIOTECHNOLOGY
$5.44
-2.94% today
Updated 2026-06-05
Market cap
$861.81M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$2 – $7
Volume
2.4M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-4.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$13.12
+141.18%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.12x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -4.30 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-46.80M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-138.29M | $-134.24M | $-138.20M | $-206.69M | $-44.14M |
| EPS | — | — | — | — | $-1.20 |
| Free cash flow | $-122.83M | $-121.33M | $-118.02M | $-186.49M | $-46.80M |
| Profit margin | — | — | — | — | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-11 | CARSON, WILLIAM H. | Buy | 8,000 | $5.78 |
| 2026-04-10 | CARSON, WILLIAM H. | Buy | 8,000 | $6.20 |
| 2026-03-10 | CARSON, WILLIAM H. | Buy | 8,000 | $5.67 |
Peer comparison
Smart narrative
Annexon Inc trades at $5.44. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -4.30, it sits in the distress.
Frequently asked questions
What is Annexon Inc's stock price?
Annexon Inc (ANNX) trades at $5.44.
Is Annexon Inc overvalued?
Annexon Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Annexon Inc (ANNX)?
The 12-month analyst consensus target is $13.12, about 141.2% above the current $5.44. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Annexon Inc's Altman Z-Score is -4.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-96.06%
Beta1.22
50D MA$5.64
200D MA$4.56
Shares out0.16B
Float0.13B
Short ratio—
Avg volume2.4M
Performance
1 week+0.00%
1 month+1.54%
3 months-6.54%
YTD+5.38%
1 year—
3 years—
5 years—